Why the study?
Does L-arginine, L-citrulline, and antioxidant supplementation reduce the progression of atherosclerosis in a high-cholesterol diet rabbit model?
Does L-arginine, L-citrulline, and antioxidant supplementation reduce the progression of atherosclerosis in a high-cholesterol diet rabbit model?
Ingestion of L-arginine, L-citrulline, and antioxidants reverses the progression of atherosclerosis and oxidative stress in a hypercholesterolemic rabbit model.
No immediate clinical implications; leaves open translation of L-arginine/citrulline benefits to human atherosclerosis.
The objective of this study was to evaluate the influence of ingested l -arginine, l -citrulline, and antioxidants (vitamins C and E) on the progression of atherosclerosis in rabbits fed a high-cholesterol diet. The fatty diet caused a marked impairment of endothelium-dependent vasorelaxation in isolated thoracic aorta and blood flow in rabbit ear artery in vivo , the development of atheromatous lesions and increased superoxide anion production in thoracic aorta, and increased oxidation-sensitive gene expression [Elk-1 and phosphorylated cAMP response element-binding protein]. Rabbits were treated orally for 12 weeks with l -arginine, l -citrulline, and/or antioxidants. l -arginine plus l -citrulline, either alone or in combination with antioxidants, caused a marked improvement in endothelium-dependent vasorelaxation and blood flow, dramatic regression in atheromatous lesions, and decrease in superoxide production and oxidation-sensitive gene expression. These therapeutic effects were associated with concomitant increases in aortic endothelial NO synthase expression and plasma [12pt]{minimal} {amsmath} {wasysym} {amsfonts} {amssymb} {amsbsy} {mathrsfs} {}{-69pt} {document} {equation*}{N}{O}₂⁻+{N}{O}₃⁻{equation*}{document} and cGMP levels. These observations indicate that ingestion of certain NO-boosting substances, including l -arginine, l -citrulline, and antioxidants, can abrogate the state of oxidative stress and reverse the progression of atherosclerosis. This approach may have clinical utility in the treatment of atherosclerosis in humans.
No takes yet. Share an insight, caveat, or question.
Hayashi et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: